D. Drekonja

发表

Use of a Computer Decision Support System and Antimicrobial Therapy Appropriateness

Bobbie T. Masoud, Meredith K. Eilertson, T. Rector, 2013, Infection Control & Hospital Epidemiology.

Promoting de-implementation of inappropriate antimicrobial use in cardiac device procedures by expanding audit and feedback: protocol for hybrid III type effectiveness/implementation quasi-experimental study

Marlena H. Shin, M. Rodriguez‐Barradas, D. Drekonja, 2022, Implementation Science.

Urinary tract infection in male veterans: treatment patterns and outcomes.

T. Rector, D. Drekonja, James R. Johnson, 2013, JAMA internal medicine.

Urinary Tract Infections

D. Drekonja, James R. Johnson, 2003 .

Protocol to disseminate a hospital-site controlled intervention using audit and feedback to implement guidelines concerning inappropriate treatment of asymptomatic bacteriuria

N. Petersen, A. Naik, S. Hysong, 2018, Implementation Science.

Antimicrobial Stewardship in Outpatient Settings: A Systematic Review

T. Wilt, R. MacDonald, I. Rutks, 2014, Infection Control & Hospital Epidemiology.

Antimicrobial Stewardship Programs in Outpatient Settings: A Systematic Review

T. Wilt, R. MacDonald, I. Rutks, 2014 .

Teamwork and safety climate affect antimicrobial stewardship for asymptomatic bacteriuria

A. Naik, S. Hysong, J. Kramer, 2019, Infection Control & Hospital Epidemiology.

Diagnostic Microbiology and Infectious Disease

D. Drekonja, 2013 .

Treatment Patterns and Outcomes

T. Rector, D. Drekonja, James R. Johnson, 2017 .

A closer inspection of tedizolid.

D. Drekonja, 2015, The Lancet. Infectious diseases.

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.

S. Saint, A. Schaeffer, S. Geerlings, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America

S. Saint, A. Schaeffer, S. Geerlings, 2019 .

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.

S. Saint, A. Schaeffer, S. Geerlings, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

No Clinical Benefit to Treating Male Urinary Tract Infection Longer Than Seven Days: An Outpatient Database Study

J. Salemi, B. Trautner, D. Drekonja, 2019, Open forum infectious diseases.

Organizational Readiness Assessment in Acute and Long-Term Care has Important Implications for Antibiotic Stewardship for Asymptomatic Bacteriuria.

C. Helfrich, A. Sales, J. Van, 2020, American journal of infection control.

Comparative Sensitivity of Transthoracic and Transesophageal Echocardiography in Diagnosis of Infective Endocarditis Among Veterans With Staphylococcus aureus Bacteremia

M. Kuskowski, V. Morrison, G. Filice, 2017, Open forum infectious diseases.

Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance.

D. Drekonja, E. Enns, Kyueun Lee, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Unnecessary Antimicrobial Use in Patients with Current or Recent Clostridium difficile Infection

M. Kuskowski, D. Drekonja, James R. Johnson, 2013, Infection Control & Hospital Epidemiology.

Study Protocol: Seven vs. 14 days treatment for afebrile men with urinary tract infection

B. Trautner, D. Drekonja, James R. Johnson, 2021, Contemporary clinical trials communications.

Urinary Tract Infections in Male Veterans With Human Immunodeficiency Virus

T. Rector, D. Drekonja, A. Cutting, 2014, Open forum infectious diseases.

Time to redefine the duration of antimicrobial treatment in male patients with urinary infections--reply.

D. Drekonja, 2013, JAMA internal medicine.

Urinary tract infections.

D. Drekonja, James R. Johnson, 2003, Primary care.

Appropriateness of urinary tract infection diagnosis and treatment duration.

M. Kuskowski, D. Drekonja, James R. Johnson, 2010, Archives of internal medicine.

Marlena H. Shin, M. Rodriguez‐Barradas, D. Drekonja, 2021, Implementation Science.

A survey of resident physicians' knowledge regarding urine testing and subsequent antimicrobial treatment.

M. Kuskowski, D. Drekonja, James R. Johnson, 2013, American journal of infection control.

Erysipelothrix bacteremia without endocarditis: rare event or under-reported occurrence?

D. Drekonja, 2013, Diagnostic microbiology and infectious disease.

Resident Physician Prescribing Variability Demonstrates Need for Antimicrobial Stewardship in Continuity Clinic: A Pilot Study.

D. Drekonja, A. Beaudoin, S. Andrews, 2020, Journal of graduate medical education.

Effectiveness of early diagnosis, prevention, and treatment of Clostridium difficile infection

T. Wilt, R. MacDonald, T. Rector, 2011 .

Analysis of an Antibiotic Stewardship Program for Asymptomatic Bacteriuria in the Veterans Affairs Health Care System

A. Naik, S. Hysong, D. Ramsey, 2022, JAMA network open.

Rapid access to comprehensive care may explain better outcomes in persons with sepsis with solid organ transplant versus those without solid organ transplant.

D. Drekonja, A. Beaudoin, N. Bahr, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

RISK OF BIAS CRITERIA

T. Wilt, R. MacDonald, I. Rutks, 2013 .

Timing of Patient Management Decisions Relative to Echocardiography in Staphylococcus aureus Bacteremia: A Single-Center Retrospective Analysis

D. Drekonja, Bruce Aldred, Bruce M Aldred, 2022, Open forum infectious diseases.

Internet survey of Foley catheter practices and knowledge among Minnesota nurses.

J. R. Johnson, M. Kuskowski, D. Drekonja, 2010, American journal of infection control.

1087. Aortic Graft Infections Caused by Propionibacterium acnes at the Minneapolis Veterans Affairs Health Care System (MVAHCS) 2007–2017

D. Drekonja, A. El Rafei, 2018, Open Forum Infectious Diseases.

Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review

T. Wilt, R. MacDonald, I. Rutks, 2014, Infection Control & Hospital Epidemiology.

Continuous Deep Sedation Until Death in Belgium: A Nationwide Survey

M. Kuskowski, D. Drekonja, James R. Johnson, 2010 .

Fecal Microbiota Transplantation for Clostridium difficile Infection

T. Wilt, R. MacDonald, D. Drekonja, 2015, Annals of Internal Medicine.

Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update

T. Wilt, N. Shippee, D. Drekonja, 2016 .

Comparative Effectiveness of Clostridium difficile Treatments

T. Wilt, R. MacDonald, T. Rector, 2011, Annals of Internal Medicine.

Fecal Microbiota Transplantation for Clostridium difficile Infection

T. Wilt, R. MacDonald, D. Drekonja, 2015, Annals of Internal Medicine.

Antimicrobial use and risk for recurrent Clostridium difficile infection.

M. Kuskowski, D. Drekonja, James R. Johnson, 2011, The American journal of medicine.

Asymptomatic Bacteriuria: To Treat or Not to Treat

D. Drekonja, 2009 .

Table 2 : Prevalence of Asymptomatic Bacteriuria in Selected Populations

D. Drekonja, 2022 .

Aspergillus Osteomyelitis Secondary to Chronic Necrotizing Pulmonary Aspergillosis in a Patient With Rheumatoid Arthritis

J. R. Johnson, D. Drekonja, A. Kaka, 2021, Cureus.

Treatment of non-life-threatening methicillin-resistant Staphylococcus aureus infections with alternative antimicrobial agents: a 2-year retrospective review.

D. Drekonja, James R. Johnson, D. DeCarolis, 2007, Diagnostic microbiology and infectious disease.

Urine Cultures among Hospitalized Veterans: Casting Too Broad a Net?

M. Kuskowski, D. Drekonja, James R. Johnson, 2014, Infection Control & Hospital Epidemiology.

Identification of Novel Factors Associated with Inappropriate Treatment of Asymptomatic Bacteriuria in Acute and Long-term Care.

B. Trautner, D. Drekonja, L. Grigoryan, 2022, American journal of infection control.

Antimicrobial urinary catheters: a systematic review

T. Wilt, M. Kuskowski, D. Drekonja, 2008, Expert review of medical devices.

Resident Physician Knowledge of Urine Testing and Treatment Over Four Years

M. Kuskowski, D. Drekonja, James R. Johnson, 2018, Infection Control & Hospital Epidemiology.

Foley catheter practices and knowledge among Minnesota physicians.

M. Kuskowski, D. Drekonja, James R. Johnson, 2010, American journal of infection control.

Clostridium difficile infection: current, forgotten and emerging treatment options.

D. Drekonja, 2014, Journal of comparative effectiveness research.

Tigecycline Treatment for Urinary Tract Infections: Case Report and Literature Review

D. Drekonja, D.M. Drekonja, J.R. Johnson, 2011, Journal of chemotherapy.

Patient Knowledge and Attitudes About Fecal Microbiota Therapy for Clostridium difficile Infection.

D. Drekonja, N. O'Rourke, Carla Amundson, 2017, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

The Erosion of Public Trust and SARS-CoV-2 Vaccines— More Action Is Needed

D. Drekonja, Jonathan D. Alpern, A. Nahum, 2021, Open forum infectious diseases.

Table 4, Outcomes Reported in Studies of Provider Feedback

Timothy J Wilt, Dimitri Drekonja, Gregory Filice, 2014 .

Antimicrobial Stewardship Programs in Inpatient Settings

T. Wilt, R. MacDonald, I. Rutks, 2013 .

Decreased antimicrobial prescribing rate following academic detailing of resident physicians in outpatient clinic

D. Drekonja, A. Gravely, A. Beaudoin, 2023, Antimicrobial Stewardship and Healthcare Epidemiology.

Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial.

J. R. Johnson, M. Kuskowski, B. Trautner, 2021, JAMA.

Diagnostic Errors that Lead to Inappropriate Antimicrobial Use

Bobbie T. Masoud, G. Filice, D. Drekonja, 2015, Infection Control & Hospital Epidemiology.

The Niche for Escherichia coli Sequence Type 131 Among Veterans: Urinary Tract Abnormalities and Long-Term Care Facilities

M. Kuskowski, D. Drekonja, James R. Johnson, 2016, Open Forum Infectious Diseases.

Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment

D. Gerding, D. Drekonja, Jane H. Zhang, 2021, Clinical trials.

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.

S. Saint, A. Schaeffer, S. Geerlings, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fecal Microbiota Transplantation for Clostridium Difficile Infection: A Systematic Review of the Evidence

T. Wilt, R. MacDonald, D. Drekonja, 2014 .

Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update

T. Wilt, Nathan D. Shippee, D. Drekonja, 2016 .

Attributable Burden of Hospital-Onset Clostridium difficile Infection: A Propensity Score Matching Study

K., Bobbie T. Masoud, Y. Tabak, 2013, Infection Control & Hospital Epidemiology.

Further Misanalysis of Urinalysis.

D. Drekonja, 2016, JAMA internal medicine.

Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry.

D. Drekonja, Jonathan D. Alpern, Aileen Ahiskali, 2023, JAMA network open.